Abstract:Background Excessive daytime sleepiness (EDS) is one of the most common non-motor symptoms in Parkinson’s disease (PD). Previous studies showed that PD patients with EDS exhibited more severe motor and non-motor symptoms. Our recent studies revealed that BIN3 rs2280104 was negatively associated with scores of Epworth Sleepiness Scale (ESS) in PD patients. The objective of this study is to examine whether BIN3 rs2280104 shapes brain networks of PD patients and whether network metrics associated with BIN3 rs2280104 mediate the effects of BIN3 rs2280104 on EDS.Methods PD patients (n = 144) receiving functional magnetic resonance imaging in Parkinson’s Progression Markers Initiative (PPMI) database were investigated. The clinical manifestations and graphical metrics of structural and functional network were compared among different genotype groups of BIN3 rs2280104. The mediation analysis was used to explore the causal associations between network metrics modified by BIN3 rs2280104 and EDS of PD patients.Results ESS scores were associated with more severe motor and non-motor symptoms. BIN3 rs2280104 T allele was negatively associated with ESS scores in PD patients. Additionally, BIN3 rs2280104 significantly shaped structural and functional network metrics of PD patients. The nodal Cp of left superior temporal pole in functional network and the degree centrality of left calcarine in structural network were negatively associated with ESS scores, however, only the degree centrality of left calcarine in structural network mediated the effects of BIN3 rs2280104 on EDS of PD patients.Conclusions To summarize, BIN3 rs2280104 is significantly associated with EDS and network topology of PD patients. Additionally, the degree centrality of left calcarine in structural network mediated the effects of BIN3 rs2280104 on EDS. Future studies were required to identify the molecular mechanisms underlying the effects of BIN3 rs2280104 on EDS and brain network metrics of PD patients.### Competing Interest StatementThe authors have declared no competing interest.### Funding StatementThis work was supported by grants from National Natural Science Foundation of China (Grant No. 81873778, 82071415) and National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (Grant No. NRCTM(SH)-2021-03).### Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:[www.ppmiinfo.org/data][1]I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll the raw data used in the preparation of this Article were downloaded from PPMI database ([www.ppmi-info.org/data][2]). All data produced in the present study are available upon reasonable request to the authors. [1]: http://www.ppmiinfo.org/data [2]: http://www.ppmi-info.org/data

BCKDKrs14235 A Allele is Associated with Milder Motor Impairment and Altered Network Topology in Parkinson’s Disease

The Effect of the PARK16 Rs11240572 Variant on Brain Structure in Parkinson's Disease

Parkinson’s Disease-Associated Genetic Variants Synergistically Shape Brain Networks

Association Between Dystonia-Related Genetic Loci and Parkinson's Disease in Eastern China

Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease

[The association of single-nucleotide polymorphism rs6265 of the brain-derived neurotrophic factor gene with clinical features in Parkinson's disease]

BIN3 Rs2280104 T Allele is Associated with Excessive Daytime Sleepiness and Altered Network Topology in Parkinson’s Disease

Association Analysis and Polygenic Risk Score Evaluation of 38 Gwas-Identified Loci in A Chinese Population with Parkinson'S Disease

Parkinson's Disease Risk Variant rs9638616 is Non-Specifically Associated with Altered Brain Structure and Function

Impact of cognition-related single nucleotide polymorphisms on brain imaging phenotype in Parkinson's disease.

Variants in the SNCA Gene Associate with Motor Progression While Variants in the MAPT Gene Associate with the Severity of Parkinson's Disease.

Allelic variant in SLC6A3 rs393795 affects cerebral regional homogeneity and gait dysfunction in patients with Parkinson’s disease

The association between clinical phenotype of Parkinson’s disease and LRRK2 variants in China

Effects of<i>MAPT</i>rs17649553 on Structural Network Integrity and Verbal Memory in Parkinson’s Disease

Gwas-Linked Gak Locus in Parkinson'S Disease in Han Chinese and Meta-Analysis

The 712A/G polymorphism of Brain-derived neurotrophic factor is associated with Parkinson's disease but not Major Depressive Disorder in a Chinese Han population

Associative Role of HLA-DRB1 as a Protective Factor for Susceptibility and Progression of Parkinson's Disease: A Chinese Cross-Sectional and Longitudinal Study

The Association Analysis of GPNMB Rs156429 with Clinical Manifestations in Chinese Population with Parkinson's Disease

BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease

Lrrk2 A419v Variant is A Risk Factor for Parkinson'S Disease in Asian Population

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts